XML 30 R2.htm IDEA: XBRL DOCUMENT v3.6.0.2
Consolidated Balance Sheets - USD ($)
$ in Thousands
Dec. 31, 2016
Dec. 31, 2015
Current assets:    
Cash and cash equivalents $ 2,709 $ 437
Other receivables 606 54
Total current assets 3,315 491
Fixed assets, net 53 38
Total assets 3,368 529
Current liabilities:    
Trade payables 201 25
Accrued liabilities 582 149
Total current liabilities 783 174
Long term liabilities:    
Convertible notes 76 419
Derivative warrant liability 313
Total liabilities 389 419
Commitments
Temporary equity:    
Common stock of $0.01 par value; issued and outstanding: 10,702,838 shares as of December 31, 2016 500
Shareholders' equity (deficit)*:    
Preferred stock value [1] 87
Common stock of $0.01 par value; Authorized: 220,000,000 and 58,054,213 shares as of December 31, 2016, and December 31, 2015, respectively; issued and outstanding: 15,848,136 and 13,182,660 shares as of December 31, 2016, and December 31, 2015, respectively [1] 266 132
Additional paid-in capital [1] 14,465 3,089
Accumulated deficit [1] (13,035) (3,372)
Total shareholders' equity (deficit) [1] 1,696 (64)
Total liabilities and shareholders' equity (deficit) [1] $ 3,368 $ 529
[1] December 31 2015 share data represents the legal equity structure of Microbot Medical Ltd. with the number of shares adjusted to retroactively reflect the one-to-nine Reverse Stock Split effected on November 28, 2016 as well as the reverse recapitalization consummated on November 28 2016.